1
|
Ivanov YD, Malsagova KA, Goldaeva KV, Kapustina SI, Pleshakova TO, Popov VP, Kozlov AF, Galiullin RA, Shumov ID, Enikeev DV, Potoldykova NV, Ziborov VS, Petrov OF, Dolgoborodov AY, Glukhov AV, Novikov SV, Grabezhova VK, Yushkov ES, Konev VA, Kovalev OB, Archakov AI. Nanoribbon Biosensor-Based Detection of microRNA Markers of Prostate Cancer. SENSORS (BASEL, SWITZERLAND) 2023; 23:7527. [PMID: 37687982 PMCID: PMC10490786 DOI: 10.3390/s23177527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 08/19/2023] [Accepted: 08/22/2023] [Indexed: 09/10/2023]
Abstract
Prostate cancer (PC) is one of the major causes of death among elderly men. PC is often diagnosed later in progression due to asymptomatic early stages. Early detection of PC is thus crucial for effective PC treatment. The aim of this study is the simultaneous highly sensitive detection of a palette of PC-associated microRNAs (miRNAs) in human plasma samples. With this aim, a nanoribbon biosensor system based on "silicon-on-insulator" structures (SOI-NR biosensor) has been employed. In order to provide biospecific detection of the target miRNAs, the surface of individual nanoribbons has been sensitized with DNA oligonucleotide probes (oDNA probes) complementary to the target miRNAs. The lowest concentration of nucleic acids, detectable with our biosensor, has been found to be 1.1 × 10-17 M. The successful detection of target miRNAs, isolated from real plasma samples of PC patients, has also been demonstrated. We believe that the development of highly sensitive nanotechnology-based biosensors for the detection of PC markers is a step towards personalized medicine.
Collapse
Affiliation(s)
- Yuri D. Ivanov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Kristina A. Malsagova
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Kristina V. Goldaeva
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Svetlana I. Kapustina
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Tatyana O. Pleshakova
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Vladimir P. Popov
- Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia;
| | - Andrey F. Kozlov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Rafael A. Galiullin
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Ivan D. Shumov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| | - Dmitry V. Enikeev
- Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia; (D.V.E.); (N.V.P.)
| | - Natalia V. Potoldykova
- Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia; (D.V.E.); (N.V.P.)
| | - Vadim S. Ziborov
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia; (V.S.Z.); (O.F.P.); (A.Y.D.)
| | - Oleg F. Petrov
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia; (V.S.Z.); (O.F.P.); (A.Y.D.)
| | - Alexander Y. Dolgoborodov
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia; (V.S.Z.); (O.F.P.); (A.Y.D.)
| | - Alexander V. Glukhov
- JSC “Novosibirsk Plant of Semiconductor Devices with OKB”, 630082 Novosibirsk, Russia;
| | - Sergey V. Novikov
- Associate Printing-and-Publication Centre Technosphera, 125319 Moscow, Russia;
| | - Victoria K. Grabezhova
- JSC “Design Center for Biomicroelectronic Technologies “Vega””, 630082 Novosibirsk, Russia;
| | - Evgeniy S. Yushkov
- Department for Business Project Management, National Research Nuclear University “MEPhI”, 115409 Moscow, Russia
| | - Vladimir A. Konev
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (V.A.K.); (O.B.K.)
| | - Oleg B. Kovalev
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia; (V.A.K.); (O.B.K.)
| | - Alexander I. Archakov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia; (Y.D.I.); (K.A.M.); (S.I.K.); (T.O.P.); (A.F.K.); (R.A.G.); (I.D.S.); (A.I.A.)
| |
Collapse
|
2
|
Pourmadadi M, Moammeri A, Shamsabadipour A, Moghaddam YF, Rahdar A, Pandey S. Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review. BIOSENSORS 2023; 13:99. [PMID: 36671934 PMCID: PMC9856029 DOI: 10.3390/bios13010099] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Revised: 12/23/2022] [Accepted: 01/03/2023] [Indexed: 06/17/2023]
Abstract
Nowadays, diagnosing early-stage cancers can be vital for saving patients and dramatically decreases mortality rates. Therefore, specificity and sensitivity in the detection of cancer antigens should be elaborately ensured. Some early-stage cancers can be diagnosed via detecting the cancer antigen CA-125, such as ovarian cancer, and required treatments can be applied more efficiently. Thus, detection of CA-125 by employing various optical or electrochemical biosensors is a preliminary and crucial step to treating cancers. In this review, a diverse range of optical and electrochemical means of detecting CA-125 are reviewed. Furthermore, an applicable comparison of their performance and sensitivity is provided, several commercial detection kits are investigated, and their applications are compared and discussed to determine whether they are applicable and accurate enough.
Collapse
Affiliation(s)
- Mehrab Pourmadadi
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran
| | - Ali Moammeri
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran
| | - Amin Shamsabadipour
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 11155-4563, Iran
| | | | - Abbas Rahdar
- Department of Physics, University of Zabol, Zabol 98613-35856, Iran
| | - Sadanand Pandey
- Department of Chemistry, College of Natural Science, Yeungnam University, 280 Daehak-Ro, Gyeongsan 38541, Republic of Korea
| |
Collapse
|
3
|
Ivanov YD, Kapustina SI, Malsagova KA, Goldaeva KV, Pleshakova TO, Galiullin RA, Shumov ID, Kozlov AF, Glukhov AV, Grabezhova VK, Popov VP, Petrov OF, Ziborov VS, Kushlinskii NE, Alferov AA, Konev VA, Kovalev OB, Uchaikin VF, Archakov AI. "Silicon-On-Insulator"-Based Biosensor for the Detection of MicroRNA Markers of Ovarian Cancer. MICROMACHINES 2022; 14:70. [PMID: 36677130 PMCID: PMC9861449 DOI: 10.3390/mi14010070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 12/16/2022] [Accepted: 12/23/2022] [Indexed: 06/17/2023]
Abstract
Ovarian cancer is a gynecological cancer characterized by a high mortality rate and tumor heterogeneity. Its early detection and primary prophylaxis are difficult to perform. Detecting biomarkers for ovarian cancer plays a pivotal role in therapy effectiveness and affects patients' survival. This study demonstrates the detection of microRNAs (miRNAs), which were reported to be associated with ovarian cancer tumorigenesis, with a nanowire biosensor based on silicon-on-insulator structures (SOI-NW biosensor). The advantages of the method proposed for miRNA detection using the SOI-NW biosensor are as follows: (1) no need for additional labeling or amplification reaction during sample preparation, and (2) real-time detection of target biomolecules. The detecting component of the biosensor is a chip with an array of 3 µm wide, 10 µm long silicon nanowires on its surface. The SOI-NW chip was fabricated using the "top-down" method, which is compatible with large-scale CMOS technology. Oligonucleotide probes (oDNA probes) carrying sequences complementary to the target miRNAs were covalently immobilized on the nanowire surface to ensure high-sensitivity biospecific sensing of the target biomolecules. The study involved two experimental series. Detection of model DNA oligonucleotides being synthetic analogs of the target miRNAs was carried out to assess the method's sensitivity. The lowest concentration of the target oligonucleotides detectable in buffer solution was 1.1 × 10-16 M. In the second experimental series, detection of miRNAs (miRNA-21, miRNA-141, and miRNA-200a) isolated from blood plasma samples collected from patients having a verified diagnosis of ovarian cancer was performed. The results of our present study represent a step towards the development of novel highly sensitive diagnostic systems for the early revelation of ovarian cancer in women.
Collapse
Affiliation(s)
- Yuri D. Ivanov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia
| | - Svetlana I. Kapustina
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia
- Department of Cybernetics of Chemical and Technological Processes, Mendeleev University of Chemical Technology of Russia (MUCTR), 125047 Moscow, Russia
| | | | | | | | | | - Ivan D. Shumov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia
| | | | - Alexander V. Glukhov
- JSC “Novosibirsk Plant of Semiconductor Devices with OKB”, 630082 Novosibirsk, Russia
| | - Victoria K. Grabezhova
- JSC “Design Center for Biomicroelectronic Technologies “Vega””, 630082 Novosibirsk, Russia
| | - Vladimir P. Popov
- Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia
| | - Oleg F. Petrov
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia
| | - Vadim S. Ziborov
- Institute of Biomedical Chemistry (IBMC), 119121 Moscow, Russia
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia
| | | | - Alexander A. Alferov
- N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia
| | - Vladimir A. Konev
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia
| | - Oleg B. Kovalev
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia
| | - Vasiliy F. Uchaikin
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia
| | | |
Collapse
|
4
|
Lee MJ. A Label-Free and Affordable Solution to Point-of-Care Testing Devices. BIOSENSORS 2022; 12:bios12040192. [PMID: 35448252 PMCID: PMC9027250 DOI: 10.3390/bios12040192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Accepted: 03/22/2022] [Indexed: 12/04/2022]
Affiliation(s)
- Mon-Juan Lee
- Department of Bioscience Technology, Chang Jung Christian University, Tainan 71101, Taiwan;
- Department of Medical Science Industries, Chang Jung Christian University, Tainan 71101, Taiwan
| |
Collapse
|
5
|
A Methodical Review on the Applications and Potentialities of Using Nanobiosensors for Disease Diagnosis. BIOMED RESEARCH INTERNATIONAL 2022; 2022:1682502. [PMID: 35103234 PMCID: PMC8799955 DOI: 10.1155/2022/1682502] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/21/2021] [Revised: 10/23/2021] [Accepted: 01/08/2022] [Indexed: 12/11/2022]
Abstract
Presently, with the introduction of nanotechnology, the evolutions and applications of biosensors and/or nanobiosensors are becoming prevalent in various scientific domains such as environmental and agricultural sciences as well as biomedical, clinical, and healthcare sciences. Trends in these aspects have led to the discovery of various biosensors/nanobiosensors with their tremendous benefits to mankind. The characteristics of the various biosensors/nanobiosensors are primarily based on the nature of nanomaterials/nanoparticles employed in the sensing mechanisms. In the last few years, the identification, as well as the detection of biological markers linked with any form of diseases (communicable or noncommunicable), has been accomplished by several sensing procedures using nanotechnology vis-à-vis biosensors/nanobiosensors. Hence, this study employs a systematic approach in reviewing some contemporary developed exceedingly sensitive nanobiosensors alongside their biomedical, clinical, or/and healthcare applications as well as their potentialities, specifically for the detection of some deadly diseases drawn from some of the recent publications. Ways forward in the form of future trends that will advance creative innovations of the potentialities of nanobiosensors for biomedical, clinical, or/and healthcare applications particularly for disease diagnosis are also highlighted.
Collapse
|
6
|
Erdem Ö, Eş I, Saylan Y, Inci F. Unifying the Efforts of Medicine, Chemistry, and Engineering in Biosensing Technologies to Tackle the Challenges of the COVID-19 Pandemic. Anal Chem 2022; 94:3-25. [PMID: 34874149 DOI: 10.1021/acs.analchem.1c04454] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- Özgecan Erdem
- UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey
| | - Ismail Eş
- UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey
| | - Yeşeren Saylan
- Department of Chemistry, Hacettepe University, 06800 Ankara, Turkey
| | - Fatih Inci
- UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey
- Institute of Materials Science and Nanotechnology, Bilkent University, 06800 Ankara, Turkey
| |
Collapse
|
7
|
Zhao W, Hu J, Liu J, Li X, Sun S, Luan X, Zhao Y, Wei S, Li M, Zhang Q, Huang C. Si nanowire Bio-FET for electrical and label-free detection of cancer cell-derived exosomes. MICROSYSTEMS & NANOENGINEERING 2022; 8:57. [PMID: 35655901 PMCID: PMC9151647 DOI: 10.1038/s41378-022-00387-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Revised: 03/17/2022] [Accepted: 04/13/2022] [Indexed: 05/11/2023]
Abstract
Exosomes are highly important in clinical diagnosis due to their high homology with their parental cells. However, conventional exosome detection methods still face the challenges of expensive equipment, low sensitivity, and complex procedures. Field effect transistors (FETs) are not only the most essential electronic component in the modern microelectronics industry but also show great potential for biomolecule detection owing to the advantages of rapid response, high sensitivity, and label-free detection. In this study, we proposed a Si nanowire field-effect transistor (Si-NW Bio-FET) device chemically modified with specific antibodies for the electrical and label-free detection of exosomes. The Si-NW FETs were fabricated by standard microelectronic processes with 45 nm width nanowires and packaged in a polydimethylsiloxane (PDMS) microfluidic channel. The nanowires were further modified with the specific CD63 antibody to form a Si-NW Bio-FET. The use of the developed Si-NW Bio-FET for the electrical and label-free detection of exosomes was successfully demonstrated with a limit of detection (LOD) of 2159 particles/mL. In contrast to other technologies, in this study, Si-NW Bio-FET provides a unique strategy for directly quantifying and real-time detecting exosomes without labeling, indicating its potential as a tool for the early diagnosis of cancer.
Collapse
Affiliation(s)
- Wenjie Zhao
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
- School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049 People’s Republic of China
| | - Jiawei Hu
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
- School of Information Science and Technology, North China University of Technology, Beijing, 100144 People’s Republic of China
| | - Jinlong Liu
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
| | - Xin Li
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
- School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049 People’s Republic of China
| | - Sheng Sun
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
| | - Xiaofeng Luan
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
- School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049 People’s Republic of China
| | - Yang Zhao
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
| | - Shuhua Wei
- School of Information Science and Technology, North China University of Technology, Beijing, 100144 People’s Republic of China
| | - Mingxiao Li
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
| | - Qingzhu Zhang
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
| | - Chengjun Huang
- Institute of Microelectronics, Chinese Academy of Sciences, Beijing, 100029 People’s Republic of China
- School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049 People’s Republic of China
| |
Collapse
|
8
|
Aptamer-Sensitized Nanoribbon Biosensor for Ovarian Cancer Marker Detection in Plasma. CHEMOSENSORS 2021. [DOI: 10.3390/chemosensors9080222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
The detection of CA 125 protein in buffer solution with a silicon-on-insulator (SOI)-based nanoribbon (NR) biosensor was experimentally demonstrated. In the biosensor, sensor chips, bearing an array of 12 nanoribbons (NRs) with n-type conductance, were employed. In the course of the analysis with the NR biosensor, the target protein was biospecifically captured onto the surface of the NRs, which was sensitized with covalently immobilized aptamers against CA 125. Atomic force microscopy (AFM) and mass spectrometry (MS) were employed in order to confirm the formation of the probe–target complexes on the NR surface. Via AFM and MS, the formation of aptamer–antigen complexes on the surface of SOI substrates with covalently immobilized aptamers against CA 125 was revealed, thus confirming the efficient immobilization of the aptamers onto the SOI surface. The biosensor signal, resulting from the biospecific interaction between CA 125 and the NR-immobilized aptamer probes, was shown to increase with an increase in the target protein concentration. The minimum detectable CA 125 concentration was as low as 1.5 × 10−17 M. Moreover, with the biosensor proposed herein, the detection of CA 125 in the plasma of ovarian cancer patients was demonstrated.
Collapse
|
9
|
Nanoribbon-Based Electronic Detection of a Glioma-Associated Circular miRNA. BIOSENSORS-BASEL 2021; 11:bios11070237. [PMID: 34356707 PMCID: PMC8301916 DOI: 10.3390/bios11070237] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 07/08/2021] [Accepted: 07/09/2021] [Indexed: 12/29/2022]
Abstract
Nanoribbon chips, based on “silicon-on-insulator” structures (SOI-NR chips), have been fabricated. These SOI-NR chips, whose surface was sensitized with covalently immobilized oligonucleotide molecular probes (oDNA probes), have been employed for the nanoribbon biosensor-based detection of a circular ribonucleic acid (circRNA) molecular marker of glioma in humans. The nucleotide sequence of the oDNA probes was complimentary to the sequence of the target oDNA. The latter represents a synthetic analogue of a glioma marker—NFIX circular RNA. In this way, the detection of target oDNA molecules in a pure buffer has been performed. The lowest concentration of the target biomolecules, detectable in our experiments, was of the order of ~10−17 M. The SOI-NR sensor chips proposed herein have allowed us to reveal an elevated level of the NFIX circular RNA in the blood of a glioma patient.
Collapse
|
10
|
Malsagova KA, Pleshakova TO, Kozlov AF, Galiullin RA, Popov VP, Tikhonenko FV, Glukhov AV, Ziborov VS, Shumov ID, Petrov OF, Generalov VM, Cheremiskina AA, Durumanov AG, Agafonov AP, Gavrilova EV, Maksyutov RA, Safatov AS, Nikitaev VG, Pronichev AN, Konev VA, Archakov AI, Ivanov YD. Detection of Influenza Virus Using a SOI-Nanoribbon Chip, Based on an N-Type Field-Effect Transistor. BIOSENSORS-BASEL 2021; 11:bios11040119. [PMID: 33921281 PMCID: PMC8069153 DOI: 10.3390/bios11040119] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 03/26/2021] [Accepted: 04/07/2021] [Indexed: 02/05/2023]
Abstract
The detection of influenza A virions with a nanoribbon detector (NR detector) has been demonstrated. Chips for the detector have been fabricated based on silicon-on-insulator nanoribbon structures (SOI nanoribbon chip), using a complementary metal-oxide-semiconductor (CMOS)-compatible technology—by means of gas-phase etching and standard optical photolithography. The surface of the SOI nanoribbon chip contains a matrix of 10 nanoribbon (NR) sensor elements. SOI nanoribbon chips of n-type conductance have been used for this study. For biospecific detection of target particles, antibodies against influenza virus have been covalently immobilized onto NRs. Influenza A virus detection was performed by real-time registration of the source-drain current through the NRs. The detection of the target viral particles was carried out in buffer solutions at the target particles concentration within the range from 107 to 103 viral particles per milliliter (VP/mL). The lowest detectable concentration of the target viral particles was 6 × 10−16 M (corresponding to 104 VP/mL). The use of solutions containing ~109 to 1010 VP/mL resulted in saturation of the sensor surface with the target virions. In the saturation mode, detection was impossible.
Collapse
Affiliation(s)
- Kristina A. Malsagova
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
- Correspondence: ; Tel.: +7-499-246-3761
| | - Tatyana O. Pleshakova
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| | - Andrey F. Kozlov
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| | - Rafael A. Galiullin
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| | - Vladimir P. Popov
- Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia; (V.P.P.); (F.V.T.)
| | - Fedor V. Tikhonenko
- Rzhanov Institute of Semiconductor Physics, Siberian Branch of Russian Academy of Sciences, 630090 Novosibirsk, Russia; (V.P.P.); (F.V.T.)
| | - Alexander V. Glukhov
- JSC Novosibirsk Plant of Semiconductor Devices with OKB, 630082 Novosibirsk, Russia;
| | - Vadim S. Ziborov
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia;
| | - Ivan D. Shumov
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| | - Oleg F. Petrov
- Joint Institute for High Temperatures of Russian Academy of Sciences, 125412 Moscow, Russia;
| | - Vladimir M. Generalov
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Anastasia A. Cheremiskina
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Alexander G. Durumanov
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Alexander P. Agafonov
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Elena V. Gavrilova
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Rinat A. Maksyutov
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Alexander S. Safatov
- Federal Budgetary Research Institution—State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being, 630559 Novosibirsk Region, Koltsovo, Russia; (V.M.G.); (A.A.C.); (A.G.D.); (A.P.A.); (E.V.G.); (R.A.M.); (A.S.S.)
| | - Valentin G. Nikitaev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia; (V.G.N.); (A.N.P.)
| | - Alexander N. Pronichev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia; (V.G.N.); (A.N.P.)
| | - Vladimir A. Konev
- Department of Infectious Diseases in Children, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia;
| | - Alexander I. Archakov
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| | - Yuri D. Ivanov
- Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, 119121 Moscow, Russia; (T.O.P.); (A.F.K.); (R.A.G.); (V.S.Z.); (I.D.S.); (A.I.A.); (Y.D.I.)
| |
Collapse
|